Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Lin

Showing results (181-190 of 287) with videos related to

Pageof 29
Sort By:
Nature Communications|November 11, 2022
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunityDeyong Jia, Zhicheng Zhou, Oh-Joon Kwon, et al.
European Urology|February 14, 2018
Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance StudyJames T Kearns, Anna V Faino, Lisa F Newcomb, et al.
European Urology|March 31, 2015
Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk CalculatorDonna P Ankerst, Jing Xia, Ian M Thompson, et al.
Annals of Internal Medicine|November 29, 2017
Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance CohortsLurdes Y T Inoue, Daniel W Lin, Lisa F Newcomb, et al.
The Prostate|October 5, 2023
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Molecular Oncology|February 2, 2017
Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancerRohina Rubicz, Shanshan Zhao, Jonathan L Wright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2018
Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921Maha Hussain, Catherine M Tangen, Ian M Thompson, et al.
JAMA Network Open|June 14, 2024
Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data LinkageMichael S Leapman, Julian Ho, Yang Liu, et al.
Urologic Oncology|August 26, 2022
Changes in skeletal muscle and adipose tissue during cytotoxic chemotherapy for testicular germ cell carcinoma and associations with adverse eventsAnthea Phuong, J Peter Marquardt, Ryan O'Malley, et al.
Cancer|October 23, 2019
Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohortsJane M Lange, Aaron A Laviana, David F Penson, et al.
Pageof 29

Showing results (181-190 of 287) with videos related to

Sort By:
Pageof 29
Nature Communications|November 11, 2022
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunityDeyong Jia, Zhicheng Zhou, Oh-Joon Kwon, et al.
European Urology|February 14, 2018
Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance StudyJames T Kearns, Anna V Faino, Lisa F Newcomb, et al.
European Urology|March 31, 2015
Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk CalculatorDonna P Ankerst, Jing Xia, Ian M Thompson, et al.
Annals of Internal Medicine|November 29, 2017
Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance CohortsLurdes Y T Inoue, Daniel W Lin, Lisa F Newcomb, et al.
The Prostate|October 5, 2023
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Molecular Oncology|February 2, 2017
Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancerRohina Rubicz, Shanshan Zhao, Jonathan L Wright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2018
Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921Maha Hussain, Catherine M Tangen, Ian M Thompson, et al.
JAMA Network Open|June 14, 2024
Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data LinkageMichael S Leapman, Julian Ho, Yang Liu, et al.
Urologic Oncology|August 26, 2022
Changes in skeletal muscle and adipose tissue during cytotoxic chemotherapy for testicular germ cell carcinoma and associations with adverse eventsAnthea Phuong, J Peter Marquardt, Ryan O'Malley, et al.
Cancer|October 23, 2019
Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohortsJane M Lange, Aaron A Laviana, David F Penson, et al.
Pageof 29